New pill aims to slow Alzheimer's before symptoms worsen

NCT ID NCT06402838

Ongoing Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 35 times

Summary

This study tests an experimental daily pill (RO7269162) in 256 people who are at risk for or have very early Alzheimer's disease. Participants either have brain plaques but no symptoms, or mild cognitive impairment. The trial checks safety and whether the drug reduces amyloid plaques in the brain over about 1.5 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Aarhus Universitetshospital Skejby

Aarhus N, 8200, Denmark
Ambulates Gesundheitszentrum der Charité GmbH

Berlin, 12200, Germany
CHU de Rouen Hopital

Rouen, 76031, France
Centro de Investigación Clínica UC-CICUC

Santiago, 8330034, Chile
Charing Cross Hospital

London, W6 8RF, United Kingdom
Complejo Asistencial Universitario de Salamanca

Salamaca, Salamanca, 37007, Spain
ECRC Experimental and Clinical Research Center, Charité Campus Berlin Buch, Memory Clinic

Berlin, 13125, Germany
ETG Neuroscience Sp. z o.o.

Warsaw, 02-777, Poland
EUROMEDIS Sp z o o

Szczecin, 70-111, Poland
Fondazione Istituto Neurologico Mondino IRCCS

Pavia, Lombardy, 27100, Italy
Fundacio ACE

Barcelona, 08028, Spain
Gachon University Gil Medical Center

Incheon, 21565, South Korea
Gerontopole

Toulouse, 31059, France
Groupement Hospitalier Est - Hôpital Neurologique

Bron, 69677, France
Hop Guillaume Et Rene Laennec

Saint-Herblain, 44800, France
Hopital B Roger Salengro

Lille, 59037, France
Hospital Clinico Univ de Chile

Santiago, Chile
Hospital General De Catalunya

Sant Cugat del Vallès, Barcelona, 8195, Spain
Hospital Quiron de Madrid

Pozuelo de Alarcón, Madrid, 28223, Spain
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
Hospital Universitario Dr. Peset

Valencia, 46017, Spain
Hospital Universitario Reina Sofia

Córdoba, 14004, Spain
Hospital Universitario la Fe

Valencia, 46026, Spain
Hospital Victoria Eugenia

Seville, 41009, Spain
Hospital Virgen del Rocío

Seville, 41013, Spain
Hôpital Lariboisière

Paris, 75010, France
Hôpital Robertsau

Strasbourg, 67000, France
Hôpital de la Timone

Marseille, 13385, France
IRCCS Ospedale San Raffaele

Milan, Lombardy, 20132, Italy
Inha University Hospital

Incheon, 22332, South Korea
Manchester Mental Health and Social Care Trust

Manchester, M13 9WL, United Kingdom
NEURO-CARE Sp. z o.o. Sp. Komandytowa

Katowice, 40-749, Poland
NZOZ Vitamed

Bydgoszcz, 85-079, Poland
NZOZ WCA

Wroc?aw, 53-659, Poland
Ospedale Cardinale Panico

Tricase (LE), Apulia, 73039, Italy
Podlaskie Centrum Psychogeriatrii

Bia?ystok, 15-756, Poland
Policlínica Guipuzcoa

Donostia / San Sebastian, Guipuzcoa, 20014, Spain
ProNeuro Centrum Medyczne

?ory, 44-240, Poland
RE:Cognition Health

London, W1G 8TA, United Kingdom
Rigshospitalet, Hukommelsesklinikken

Koebenhavn Oe, 2100, Denmark
Scottish Brain Sciences

Edinburgh, EH12 9DQ, United Kingdom
Senior Sp. Z O.O. Poradnia Psychogeriatryczna

Sopot, 81-855, Poland
Southampton General Hospital

Southampton, SO16 6YD, United Kingdom
Surrey and Borders NHS Foundation Trust

Chertsey, KT16 9AU, United Kingdom
Szpital Uniwersytecki w Krakowie

Krakow, 30-688, Poland
TUM Klinikum rechts der Isar;Ambulanz für neurokognitive Erkrankungen

München, 81675, Germany
Umberto I Policlinico di Roma-Università di Roma La Sapienza

Rome, Lazio, 00185, Italy

Conditions

Explore the condition pages connected to this study.

ALZHEIMER'S DISEASE